CytoMed Therapeutics Quote - GDTC

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.64

Bid

2.35

Offer

2.65

Volume

10,138

2.52 Day's Range 2.64

1.20 52 Week Range 3.98

Market Cap

30.466M

Previous Close

2.59

Open

2.52

Last Trade

2.4

Last Trade Time

Financial Volume

US$ 26,132

VWAP

2.5776

Average Volume (3m)

230,816

Shares Outstanding

11,540,000

Dividend Yield

PE Ratio

-7.37

Earnings Per Share (EPS)

-0.36

Revenue

518k

Net Profit

-4.13M

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing C... CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.cytomed.sg.

Headquarters

Singapore, Sgp

Founded

CytoMed Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GDTC. The last closing price for CytoMed Therapeutics was US$2.59. Over the last year, CytoMed Therapeutics shares have traded in a share price range of US$ 1.20 to US$ 3.98.

CytoMed Therapeutics currently has 11,540,000 shares in issue. The market capitalisation of CytoMed Therapeutics is US$29.89 million. CytoMed Therapeutics has a price to earnings ratio (PE ratio) of -7.37.

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers in a proposed Phase 2 clinical trial

SINGAPORE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies

SINGAPORE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Further to an announcement on October 7, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based...

Form 144 - Report of proposed sale of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant

SINGAPORE, Oct. 07, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.17	6.88259109312	2.47	2.71	2.32	16667	2.54749478	CS
4	-0.86	-24.5714285714	3.5	3.98	2.12	684202	3.35690122	CS
12	0.11	4.34782608696	2.53	3.98	1.8302	230816	3.32748748	CS
26	0.85	47.4860335196	1.79	3.98	1.2	106291	3.2601263	CS
52	-0.86	-24.5714285714	3.5	3.98	1.2	75477	2.98688271	CS
156	-1.36	-34	4	9.25	1.2	119766	4.28377505	CS
260	-1.36	-34	4	9.25	1.2	119766	4.28377505	CS

GDTC - Frequently Asked Questions (FAQ)

What is the current CytoMed Therapeutics share price?

The current share price of CytoMed Therapeutics is US$ 2.64

How many CytoMed Therapeutics shares are in issue?

CytoMed Therapeutics has 11,540,000 shares in issue

What is the market cap of CytoMed Therapeutics?

The market capitalisation of CytoMed Therapeutics is USD 29.89M

What is the 1 year trading range for CytoMed Therapeutics share price?

CytoMed Therapeutics has traded in the range of US$ 1.20 to US$ 3.98 during the past year

What is the PE ratio of CytoMed Therapeutics?

The price to earnings ratio of CytoMed Therapeutics is -7.37

What is the cash to sales ratio of CytoMed Therapeutics?

The cash to sales ratio of CytoMed Therapeutics is 58.8

What is the reporting currency for CytoMed Therapeutics?

CytoMed Therapeutics reports financial results in SGD

What is the latest annual turnover for CytoMed Therapeutics?

The latest annual turnover of CytoMed Therapeutics is SGD 518k

What is the latest annual profit for CytoMed Therapeutics?

The latest annual profit of CytoMed Therapeutics is SGD -4.13M

What is the registered address of CytoMed Therapeutics?

The registered address for CytoMed Therapeutics is #08-22 ONE COMMONWEALTH, 1 COMMONWEALTH LANE, SINGAPORE, 149544

What is the CytoMed Therapeutics website address?

The website address for CytoMed Therapeutics is www.cytomed.sg.

Which industry sector does CytoMed Therapeutics operate in?

CytoMed Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
REBNReborn Coffee Inc	US$ 3.31 (63.05%)	55.54M
FCUVFocus Universal Inc	US$ 5.87 (56.62%)	1.73M
SOPASociety Pass Inc	US$ 1.54 (56.50%)	13.82M
CYCNCyclerion Therapeutics Inc	US$ 3.92 (54.33%)	82.39M
ENVBEnveric Biosciences Inc	US$ 2.0899 (-46.41%)	1.57M
NIVFNewGenIvf Group Ltd	US$ 0.1489 (-42.51%)	14.8M
GLSTGlobal Star Acquisition Inc	US$ 8.83 (-39.10%)	23.89k
PRPHProPhase Labs Inc	US$ 0.2633 (-38.02%)	872.46k
SPGCSacks Parente Golf Inc	US$ 0.5601 (-37.86%)	7.27M
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
NVDANVIDIA Corporation	US$ 120.07 (-3.67%)	388.54M
RIMEAlgorhythm Holdings Inc	US$ 0.02565 (5.12%)	338.75M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0355 (-11.25%)	236.29M
CLEUChina Liberal Education Holdings Ltd	US$ 0.1938 (30.77%)	234.8M